Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
85.61
+2.52 (3.03%)
Oct 14, 2025, 3:42 PM EDT - Market open
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$435,129
Profits / Employee
-$93,258
Market Cap
4.91B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 995 | 88 | 9.70% |
| Dec 31, 2023 | 907 | 124 | 15.84% |
| Dec 31, 2022 | 783 | 56 | 7.70% |
| Dec 31, 2021 | 727 | 74 | 11.33% |
| Dec 31, 2020 | 653 | 53 | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GKOS News
- 8 hours ago - Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting - Business Wire
- 6 days ago - Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29 - Business Wire
- 18 days ago - Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama - Business Wire
- 2 months ago - Glaukos Announces Participation in Wells Fargo Healthcare Conference - Business Wire
- 2 months ago - Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Glaukos Announces Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - Business Wire
- 3 months ago - Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - Business Wire